Immortalized Human Bone Marrow Mesenchymal Cells - hTERT

CAT.NOUNITPRICE
T05231x106 cells / 1.0 ml
$0.00

Specifications


Description

The Bone Marrow Mesenchymal Cells are important for the growth and differentiation of primitive haematopoietic cells, as well as for maintenance of leukaemic cells. The immortalized cell was created by infecting primary mesenchymal cells with retrovirus containing hTERT and GFP genes separated by IRES under the control of MSCV LTR (pCIneo-hEST2-HA). The Immortalized Bone Marrow Mesenchymal cells can support growth of leukaemic cell lines 380, REH, OP-1 and 697, in addition to support the expansion of CD34+ cells. This cell line is useful not only in supporting the growth of haematopoietic cells, but can also be used in studies concerning bone marrow microenvironment and environmental cues that regulate haematopoiesis.

SKUT0523
SpeciesHuman (H. sapiens)
Tissue/Organ/Organ SystemBone Marrow
Growth PropertiesAdherent
Cell MorphologySpindle-shaped
Seeding Density10,000 - 20,000 cells/cm2; Recommended split ratio is 1:2 to 1:3
Population Doubling Time35 - 45 hours
Immortalization MethodSerial passaging and transduction with recombinant VSV-G retrovirus carrying hTERT and GFP genes
Applications

For Research Use Only

Unit quantity1x106 cells / 1.0 ml
Cell TypeImmortalized Cells
Expression Profile

CD44, CD73; these cells also express markers of osteoblasts (alkaline phosphatise) and chondrocytes (incorporation of toluidine blue dye)

Propagation Requirements

Use of PriCoatTM T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) is required for cell adhesion to the culture vessels. Grow cells in ECM-coated culture vessels unless otherwise specified in the Propagation Requirements below.

The base medium for this cell line is Prigrow II medium available at abm, Cat. No. TM002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (TM999)* to a final concentration of 10%, Penicillin/Streptomycin Solution (G255) to a final concentration of 1%, and hydrocortisone to a final concentration of 10-6 M.
Change media every 2-3 days.
Carbon dioxide (CO2): 5%, Temperature: 37.0°C.
* Do not use heat-inactivated FBS for cell culture unless specified otherwise.

QC

1) Immunofluorescence and RT-PCR were used to confirm the presence hTERT expression; 2) PCR based TRAP was used to assay telomerase activity; 3) Neo concentration not determined for selection use but cells were sorted for GFP+ populations

Disclaimer

1. For for-profit organizations and corporations, please contact [email protected] for pricing of this item.

2. Sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchasing individual/institution for each order. If you have any questions regarding this, please contact us at [email protected].

3. All test parameters provided in the CoA are conducted using abm's standardized culture system and procedures. The stated values may vary under the end-user's culture conditions. Please verify that the product is suitable for your studies by referencing published papers or ordering RNA (0.5 μg, Cat.# C207, $450.00) or cell lysate (100 μg, Cat.# C206, $600.00) to perform preliminary experiments, or alternatively use our Gene Expression Assay Service (Cat# C138). All sales are final.

4. We recommend live cell shipments for ease of cell transfer and this option can be requested at the time of ordering. Please note that the end-user will need to evaluate the feasibility of live cell shipment by taking into account the final destination's temperature variation and its geographical location. In addition, we thoroughly test our cell lines for freeze-thaw recovery. If frozen cells were received and not recovered in your lab under the exact, specified conditions (using recommended culture vessel, media, additional supplements, and atmospheric conditions), a live cell replacement is possible at a cost (plus shipping).

5. All of abm's cell biology products are for research use ONLY and NOT for therapeutic/diagnostic applications. abm is not liable for any repercussions arising from the use of its cell biology product(s) in therapeutic/diagnostic application(s). Please contact a technical service representative for more information.

6. abm makes no warranties or representations as to the accuracy of the information on this site. Citations from literature and provided for informational purposes only. abm does not warrant that such information has been shown to be accurate.

7. abm warrants that cell lines shall be viable upon initiation of culture for a period of thirty (30) days after shipment and that they shall meet the specifications on the applicable abm Material Product Information sheet, certificate of analysis, and/or catalog description. Such thirty (30) day period is referred to herein as the "Warranty Period."

DepositorSt. Jude Children's Research Hospital
FAQs


I want to make sure these cells express my gene of interest before I decide to buy the cell line. Can you provide a sample so this can be tested?
We do not carry out downstream characterization or gene expression profiling of our cell lines. To facilitate your preliminary experiments we can provide an RNA extraction (0.5ug total RNA) or cell lysate (100ug/100ul provided in 62.5mM Tris‐HCl, 2% SDS, 10% Glycerol, 50mM DTT, 0.01% w/v Bromophenol Blue) for any of our immortalized cell lines for a small fee. Please inquire directly for more information. The lead time will be around 2 weeks from the time of placing an order (if the item is in stock).
Should the cells always be cultured in collagen coated flasks or only when they are first revived?
The use of collagen coated flasks is especially important upon thaw, as this will greatly help with cell recovery and cell adhesion to the culture ware. The end user can evaluate the need for coated flasks after cell recovery.
How often do I need to change the media?
The media should be changed every 2-3 days.
Why do these cells need bio safety level II?
In order to be more cautious, we follow the CDC-NIH recommendations that all mammalian sourced products should be handled at the Biological Safety Level 2 to minimize exposure of potentially infectious products. This information can be found in 'Biosafety in Microbiological and Biomedical Laboratories' (1999). Your institution's Safety Officer or Technical Services will be able to make the call as to whether BioSafety Level I is possible with these cells at your site if required.
Do you sell ECM coated T75 flasks?
Yes we can provide a coating service. Please inquire with [email protected]
What can I coat a larger dish to subculture?
We also offer applied extracellular matrix (collagen type I) in liquid form, for the coating of larger flasks and other required plasticware: http://www.abmgood.com/Applied-Cell-Extracellular-Matrix-G422.html
How long can I store frozen vials for?
Cells that are properly frozen using an effective cryoprotective agent can be stored in liquid nitrogen indefinitely without affecting their recovery.
Should the cap of the flask be changed before starting the cell culturing step?
No, there is no need in sterile biosafety cabinets unless it has contacted any non-sterile condition (e.g. touching the contaminated tip, etc.).
What is the recommended storage temperature?
In general, if you received: Live cells: acclimatize for 3-4 hrs at at the recommended conditions stated for the cell line under the propagation section, and then change media afterwards. Frozen cells: Immediately place cells in liquid nitrogen; -180C.
How is cell density crucial for drug selection?
If antibiotic selection is applicable to the target cells, we suggest getting rid of all the background cells so that the cell density is kept lower (even 20-30%). However, once the clones are selected by clonal dilution, we don't need the drug to still be present. If needed, the cell density should be towards the higher end since cells are already selected. Any primary cells still present will be depleted as a result of senescence and the cell population that remains will be resistant to the specific antibiotic.
My cells are not detaching, what method do you recommend to trypsinize the cells?
1. Incubate the coated plate containing trypsin solution at recommended temperature indicated in the propagation section for 3-5 min till the cells round up, monitoring from time to time under microscope. 2. Diluting G422 (1:1) with PBS and coating for lesser time. Sometimes the collagen content in G422 is higher and thus make stronger bonding with cells. 3. You can try reducing the incubation time as well for coating the plate to make a thinner layer.
Why is it important to determine the optimal seeding density?
The seeding density we recommend is for when cells are plated to a new vessel. The optimal seeding density should allow cells to attach to the surface and have room to proliferate. If you seed too little, cells may not attach well to the surface (for adherent cells). Seeding density is important as many cells (adherent or suspension cells) need to be in close proximity for better growth. Cell-cell interactions allow cells to communicate with each other in response to changes in their microenvironment. This ability to send and receive signals is essential for the survival of the cell. In other cases, if the seeding density is too low, cells may attach but a retardation in cell growth is observed. If you seed too high, the cells will attach but there is insufficient room for further proliferation and they will stop replicating.
References


24
  • Cisterne, A et al. "Silencer of death domains controls celld eath through tumour necrosis factor-receptor 1 and caspase-10 in acute lymphoblastic leukemia" PLoS One 9(7):e103383 (2014). DOI: 10.1371/journal.pone.0103383.
  • Kremer, KN et al. "Osteoblasts protect AML cells from SDF-1-induced apoptosis" J Cell Biochem 115(6):1128-1137 (2014). PubMed: 24851270.
  • Kremer, KN et al. "CXCR4 chemokine receptor signaling induces apoptosis in acute myeloid leukemia cells via regulation of the Bcl-2 family members Bcl-XL, Nova, and Bak" J Biol Chem 228(32):22899-22914 (2013). DOI: 10.1074/jbc.M113.449926.
  • Harb , JG et al. "Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target" Leukemia 27(10):1996-2005 (2013). DOI: 10.1038/leu.2013.151.
  • Kwong-Lam, F et al. "Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment " Exp Hematol Oncol 2(1):11 (2013). DOI: 10.1186/2162-3619-2-11.
  • Zhang, B et al. "Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling" Blood 121(10):1824-1838 (2013). DOI: 10.1182/blood-2012-02-412890.
  • Garcia-Gomez, A et al. "Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects " PLoS One 7(4):e34914 (2012). DOI: 10.1371/journal.pone.0034914.
  • Fujisaki , H et al. "Expansion of highly cytotoxic human natural killer cells for cancer cell therapy" Cancer Res 69(9):4010-4017 (2009). DOI: 10.1158/0008-5472.CAN-08-3712.
  • Dong, Z et al. "Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover " Neoplasia 10(5):439-449 (2008). PubMed: 18472961.
  • Dworzak, MN et al. "CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy" Blood 112(10):3982-3988 (2008). DOI: 10.1182/blood-2008-06-164129.
  • Iwamoto, S et al. "Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase " J Clin Invest 117(4):1049-1057 (2007). DOI: 10.1172/JCI30235.
  • Mihara, K et al. "Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase" Br J Haematol 120(5):846-849 (2003). PubMed: 12614220.
  • Galvan, J.A. et al. "Validation of COL11A1/procollagen 11A1 expression in TGF-β1-activated immortalised human mesenchymal cells and in stromal cells of human colon adenocarcinoma" BMC Cancer 14(1):867 (2014). PubMed: 25417197.
  • Pittenger, MF et al. "Multilineage Potential of Adult Human Mesenchymal Stem Cells" Science 5411:143-147 (1999). DOI: 10.1126/science.284.5411.143.
  • Charan, M., Dravid, P., Cam, M., Audino, A., Gross, A. C., Arnold, M. A., ... & Cam, H. "GD2‐directed CAR‐T cells in combination with HGF‐targeted neutralizing antibody (AMG102) prevent primary tumor growth and metastasis in Ewing Sarcoma" International Journal of Cancer. : (2019).